0001103021-19-000006.txt : 20190815 0001103021-19-000006.hdr.sgml : 20190815 20190815162527 ACCESSION NUMBER: 0001103021-19-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190813 FILED AS OF DATE: 20190815 DATE AS OF CHANGE: 20190815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenleaf Peter CENTRAL INDEX KEY: 0001363683 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 191030575 MAIL ADDRESS: STREET 1: ONE MEDIMMUNE WAY CITY: GAITHERSBURG STATE: MD ZIP: 20878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 4 1 wf-form4_156590070881930.xml FORM 4 X0306 4 2019-08-13 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001363683 Greenleaf Peter C/O BIODELIVERY SCIENCES INTL, INC., 4131 PARKLAKE AVE. SUITE 225 RALEIGH NC 27612 1 0 0 0 Common Stock 2019-08-13 4 M 0 21144 0 A 24788 D Restricted Stock Units 0.0 2019-08-13 4 M 0 21144 0 D 2022-08-01 Common Stock 21144.0 87500 D The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person on August 1, 2018 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest as follows: (i) 35,000 RSUs vest in the first open window following the Company's 2020 Annual Meeting of Stockholders, (ii) 35,000 RSUs vest in the first open window following the Company's 2021 Annual Meeting of Stockholders and (iii) 17,500 RSUs vest in the first open window following the Company's 2022 Annual Meeting of Stockholders. /s/ Peter Greenleaf 2019-08-15